Breast cancer: 'Life-changing' drug given go-ahead for routine NHS use

[ad_1]

A “LIFE-changing” drug for breast cancer patients has been given the final go-ahead for routine NHS use in England. The National Institute for Health and Care Excellence issued its final decision recommending Perjeta, also known as pertuzumab, for some women with breast cancer.

[ad_2]

Read More